Zyus Life Sciences Corp filed a Form D with the Securities and Exchange Commission on 2025-08-13.
Zyus Life Sciences Corp filed a Form D notice of an exempt securities offering with the SEC on August 13, 2025. The filing reports $73K sold. Its industry group is Other Health Care. It names Brett Zettl (President and CEO), John Hyshka (Chief Financial Officer), Keith Carpenter (Chief Strategy and Investment Officer) (SEC Form D, August 13, 2025).
Is this your company?
Sell to companies like Zyus Life Sciences Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Zyus Life Sciences Corp.
Free to see. No signup.
More on the people and the money behind Zyus Life Sciences Corp, from the filings we hold.
Other Health Care raises filed within 90 days of this one, largest first.
Get an email when Zyus Life Sciences Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Zyus Life Sciences Corp raises, hires or launches. No email unless you switch it on.
Watch Zyus Life Sciences Corp →Get the full cited report on Zyus Life Sciences Corp
What the filing shows about Zyus Life Sciences Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Zyus Life Sciences Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Zyus Life Sciences Corp's address as 407 Downey Road, Suite 204, Saskatoon, A9 S7N 4L8.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Zyus Life Sciences Corp See pricing
Zyus Life Sciences Corp is a registered filer with the SEC (CIK 2036745) and has filed since 2024-09-10. 3 filings are on record, the latest on 2025-08-13.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Zyus Life Sciences Corp's Form D of 2025-08-13 names Brett Zettl, John Hyshka, Keith Carpenter and 6 more as its officers, directors or promoters.
Its new offerings report $764K sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 869 filings in Other Health Care, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200, after redirecting from https://zyus.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Brett Zettl is named as President and Ceo on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
John Hyshka is named as Chief Financial Officer on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Keith Carpenter is named as Chief Strategy and Investment Officer on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Dr. Julie Stakiw is named as Chief Medical Officer on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
Richard Hoyt is named as Director on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
John Knowles is named as Director on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
Garnette Weber is named as Director on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
Wayne Brownlee is named as Director on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
Dr. Charlotte Moore Hepburn is named as Director on the Form D that Zyus Life Sciences Corp filed with the SEC on 13 August 2025, one of 9 people that filing names.
9 people named on the filing — 4 holding an executive role and 5 as directors only.
Named as of the 2025-08-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Zyus Life Sciences Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Zyus Life Sciences Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Zyus Life Sciences Corp covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Zyus Life Sciences CorpYou get an alert in MentionFox the next time this company shows up.
If you're behind Zyus Life Sciences Corp: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (zyus.com).
Each opens in a new tab, filled in for Zyus Life Sciences Corp. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/zyus-life-sciences-corp-form-d-25000001